| Application no. and date | 01201913.9 (espacenet) (Federated) (European Patent Register), 19980717 | | Patent/reg. no. and date | DK/EP 1175904, 20070328 | | Publication date | 20020130 | | Priority no. and date | US 53351 P, 19970722, US 53535 P, 19970723, GB 9717590, 19970820, GB 9717850, 19970822 | | EP pub. no. and date |
EP 1175904 20020130 | | Effective date | | | Applicant/owner | Merck Sharp & Dohme Corp., 126 East Lincoln Avenue
Rahway, NJ 07065, US | | Applicant ref. no. | P1512DKEP | | Inventor | Daifotis, Anastasia G., 126 East Lincoln Avenue
Rahway, NJ 07065, US,
Yates, John A., 126 East Lincoln Avenue
Rahway, NJ 07065, US,
Santora, Arthur C., II, 126 East Lincoln Avenue
Rahway, NJ 07065, US | | Representative | HØIBERG P/S, Adelgade 12, 1304 København K | | Opponent | | | IPC Class | A61K 31/663 (2006.01) , A61P 19/10 (2006.01) | | Title | Alendronat til anvendelse til behandling af osteoporose | | Int. application no. | | | Int. publication no. | | | Related patent (certificate) | CA 2007 00045 | | Status | Ophævet | | Pædiatrisk forlængelse | - | | Udløbsdato for pædiatrisk forlængelse | - |
|
